+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
PGHL

Procter & Gamble Health Share Price

₹5,360.00 -203 (-3.65%)

01 Oct, 2026 3:31 PM (IST)

Procter & Gamble Health live price: ₹5,360.00. It opened at ₹5,515 vs previous close ₹5,563; intraday high/low: ₹5,534/₹5,325. The 50 & 200 DMA stand at ₹5,765.40/₹5,767.20.

Procter & Gamble Health Performance

  • Today's Low
  • ₹5,325
  • Today's High
  • ₹5,534
  • 52 Week Low
  • ₹4,707
  • 52 Week High
  • ₹6,975
  • Open Price₹5,515
  • Previous Close₹5,563
  • Volume8,986
  • 50 DMA₹5,765.40
  • 100 DMA₹5,822.40
  • 200 DMA₹5,767.20

Procter & Gamble Health Chart

Investment Returns

  • Over 1 Month -7.07%
  • Over 3 Month -15.28%
  • Over 6 Month + 11.69%
  • Over 1 Year -15.02%

Smart Investing Starts Here Start SIP with Procter & Gamble Health for Steady Growth!

Invest Now

Procter & Gamble Health Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 24.9
  • PEG Ratio
  • 1.3
  • Market Cap Cr
  • 8,897
  • P/B Ratio
  • 14.3
  • Average True Range
  • 152.2
  • EPS
  • 215
  • Dividend Yield
  • 3.8
  • MACD Signal
  • -95.5
  • RSI
  • 46.83
  • MFI
  • 60.21

Latest Stock News Updates

Procter & Gamble Health Ltd - 500126 - Board Meeting Intimation for Intimation Of Board Meeting

Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve unaudited financial results for the quarter and half year ended September 30 , 2026.

Procter & Gamble Health Ltd - 500126 - Closure of Trading Window

We would like to inform you that the Trading Window of the Company shall remain closed for the Directors and Designated Employees from October 1, 2026 until 48 hours from the publication of the unaudited financial results for the quarter and half year ended September 30, 2026.

Procter & Gamble Health Ltd - 500126 - Intimation Regarding Ease Of Doing Investment - Special Window For Transfer And Dematerialization

Stock Exchange is informed about an update on Ease of doing Investment - Special Window for Transfer and Dematerialization.

Procter & Gamble Health Financials

Procter & Gamble Health Technicals

EMA & SMA

Current Price
₹5,360.00
-203 (-3.65%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹5,559.80
  • 50 Day
  • ₹5,765.40
  • 100 Day
  • ₹5,822.40
  • 200 Day
  • ₹5,767.20

Resistance and Support

5406.33 Pivot Speed
  • R3 5,864.00
  • R2 5,780.00
  • R1 5,671.50
  • S1 5,479.00
  • S2 5,395.00
  • S3 5,286.50

Procter & Gamble Health Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-02 Quarterly Results
2026-08-06 Quarterly Results
2026-05-26 Audited Results & Final Dividend
2026-02-06 Quarterly Results & Interim Dividend
2025-11-05 Quarterly Results & Interim Dividend
Date Purpose Remarks
2026-08-27 FINAL Rs.45.00 per share(450%)Final Dividend (RD & XD dates revised)
2026-02-12 SPECIAL Rs.50.00 per share(500%)Special Dividend
2026-02-12 INTERIM Rs.110.00 per share(1100%)Interim Dividend
2025-08-22 FINAL Rs.45.00 per share(450%)Final Dividend
2025-02-21 INTERIM Rs.80.00 per share(800%)Interim Dividend
View Procter & Gamble Health Dividend History Arrow

Procter & Gamble Health Shareholding Pattern

51.82%
29.41%
9.05%
6.33%
3.39%

Procter & Gamble Health FAQs

Procter & Gamble Health share price is ₹5,360 As on 01 October, 2026 | 16:16

The Market Cap of Procter & Gamble Health is ₹8897.3 Cr As on 01 October, 2026 | 16:16

The P/E ratio of Procter & Gamble Health is 24.9 As on 01 October, 2026 | 16:16

The PB ratio of Procter & Gamble Health is 14.3 As on 01 October, 2026 | 16:16

The 52 week High & Low of Procter & Gamble Health is ₹6975/₹4707 respectively As on 01 October, 2026 | 16:16

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23